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Abstract. In this work, a tool for the survivability prediction of patients
with colon or rectal cancer, up to five years after diagnosis and treatment,
is presented. Indeed, an accurate survivability prediction is a difficult
task for health care professionals and of high concern to patients, so that
they can make the most of the rest of their lives. The distinguishing
features of the tool include a balance between the number of necessary
inputs and prediction performance, being mobile-friendly, and featuring
an online learning component that enables the automatic evolution of
the prediction models upon the addition of new cases.
1 Introduction
The colorectal cancer, is a subtype of cancer, which affects the lower portion of
the gastrointestinal tract and develops in the cells lining the colon and rectum
[25]. It can be further divided according to the site where the pathology devel-
ops. Colon and rectum cancers are, in fact, different pathologies, with different
associated genetic causes and different progressions according to distinct molec-
ular pathways [30]. Statistics show that colorectal cancer is the most common
form of cancer in the digestive system, the third most common and the fourth
deadliest cancer overall [15].
The use of machine learning (ML) techniques has been growing in cancer
research [18]. The accurate prediction of survivability in patients with cancer re-
mains a challenge namely due to the heterogeneity and complexity of the disease.
However, accurate survivability prediction is important for patients with cancer
so that they can make the most of the rest of their lives. It is also important
to help clinicians to make the best decisions, when palliative care is an essential
component of the process. Given that colon and rectal are the most common can-
cers of the digestive system, one would expect the existence of numerous tools
for ascertaining the likelihood of a patient surviving this disease. Although there
are some tools for this task, few provide predictions for both colon and rectal
cancer, and none of them apply ML techniques in order to build evolving pre-
dictive models. Furthermore, their digital support may hinder their consultation
at care delivery.
The objective of this work is to present an easy to use tool that provides sur-
vivability predictions of colon and rectal cancer patients for 1, 2, 3, 4 and 5 years
after diagnosis and treatment. Due to the ubiquitous presence of mobile devices
in everyday life and the ease with which one is able to consult these devices
and use their applications, we chose to develop this tool as a mobile applica-
tion. The underlying model for survivability prediction was obtained through
ML techniques applied to the data from the Surveillance, Epidemiology, and
End Results (SEER) program [19], a large cancer registry in the United States,
and arguably the most complete cancer database in the world. The dataset in-
cludes records of patients diagnosed with different types of cancer from 1973 to
2012. The focus of this paper will be placed on the mobile solution developed
for survivability prediction, but a part of the paper will be dedicated to briefly
describing its underlying ML model so as to provide a better comprehension of
the work as a whole.
The paper is structured as follows. Section 2 presents related work featuring
survivability prediction tools for colon and rectal cancer, with an analysis of
their main strengths and limitations. Section 3 describes the selected require-
ments for the tool, its underlying ML-based predictive model, architecture and a
comprehensive use case. Section 4 provides a reflection about the strengths and
limitations of our approach. Finally, Section 5 presents the conclusions drawn so
far and future work considerations.
2 Related Work
Existing tools for colon or rectal cancer survivability prediction are mostly avail-
able as web applications. Table 1 shows a summary of their main features,
namely: (1) whether the application is used for colon or rectal cancer; (2) the
number of features necessary to get a prediction; (3) the data set that its un-
derlying model is based on; (4) the technique used to construct the predictive
model; (5) the type of target prediction it produces; and (6) a measure of perfor-
mance in the form of a concordance index (C-index). The C-index corresponds
to the probability of giving a correct response in a binary prediction problem.
It is considered to be numerically equivalent to the area under the ROC curve
(AUC) [16].
There is a disparity in the number of features used in each tool. However,
twelve [23] or even nine [10,26] features may be too much information for a
physician to input on-the-fly. Furthermore, there are cases in which the increased
number of features does not necessarily translate into a better performance, as
can be seen in the direct comparison between the works in [29] and in [23].
All the underlying models are based on statistical modelling, most notably
on Cox regression analysis [8]. This is the dominant multivariate approach used
in survivability prediction and corresponds to a multiple linear regression of
the hazard on a set of variables. This indicates that the use of soft computing
techniques, namely ML, in survivability prediction, especially in colon and rectal
cancer, has yet to be fully explored. Since one of the advantages of ML is having
Table 1: Characteristics of applications for colon and rectal cancer survivability
prediction.
Characteristics
Bush and Michaelson
(2009) [10]
Chang et al.
(2009) [11]
Weiser et al.
(2011) [29]
Renfro et al.
(2014) [23]
Wang et al.
(2011) [28]
Valentini et al.
(2011) [26]
Bowles et al.
(2013) [7]
(1)
Cancer
Type
colon colon colon colon rectal rectal rectal
(2)
Number of
Features
9 6‡ 2/3/7 12 5‡ 9 7‡
(3) Data set SEER SEER SEER
Adjuvant Colon
Cancer End
Points (ACCENT)
SEER
five European
randomized trials
SEER
(4) Model
regression
based
regression
based
regression
based
regression
based
regression
based
regression
based
regression
based
(5) Target 0 – 15 years
1 – 10 years
(disease
specific
survivability)
0 – 5 years
(conditional
survivability)
5 years 5 years 0 – 5 years 1– 10 years
1 – 10 years
(disease
specific
survivability)
0 – 5 years
(conditional
survivability)
(6)
Performance
C-index
– 0.816 0.61/0.63/0.68 0.66 0.75 0.70 –
‡ Including months which the patient has already survived (for conditional survivability calculation).
more discriminative power in identifying patterns in data and finding nuances
that may escape statistical modelling, its usage for survivability prediction may
result in models with better performances [17]. As such, ML was chosen as the
modelling approach for this work.
Most of the target predictions, either for colon or for rectal cancer, cover a
5-year span [28,29,23]. Even though there are models that cover a wider time
span [10,11,26,7], the five year barrier is an important goal for a colorectal cancer
patient to overcome, and is used throughout clinical practice guidelines [4,5] as
a turning point for follow-up procedures, in which the vigilance over the patient
is lightened, and for the assessment of the recurrence risk. For this reason, the
present work will also have a target prediction of five years. Another notewor-
thy observation is that only two of the tools feature conditional survivability
predictions.
To determine if the tools are suitable for mobile devices, the applications were
analysed using the mobile-friendly test tool from Google 3. The results showed
that, except for the tools reported in [29] and [23], all the others are unsuitable
for mobile access. The test revealed that the text was too small to read, the
mobile viewport was not set, links were too close to each other and usually the
content was wider than the screen. Therefore, few of these applications had a
mobile-friendly design. Another goal is to address this by developing a cross-
platform tool that is available to users in a practical and intuitive way, through
a smartphone or tablet.
3Mobile-friendly test tool of Google is available at
https://www.google.com/webmasters/tools/mobilefriendly/
3 CRCPredictor: An Application for Survivability
Prediction
Throughout the last decade, mobile phones have gone from being simple phones
to being handheld pocket-sized computers. Their capabilities, namely the pro-
cessing and on-board computing capacity incite the development of applications
[6]. According to data from the International Data Corporation (IDC) World-
wide Quarterly Mobile Phone Tracker, the Android of Google and iOS of Apple
are the two most popular smartphone operating systems [12].
For the health care industry, mobile applications yielded new boundaries in
providing better care and services to patients. Moreover, it is making a revolution
in the way information is managed and made available [24]. The portability of
mobile applications can increase the productivity of health care professionals. It
grants a rapid access to information and multimedia resources, allowing health
care professionals to make decisions more quickly with a lower error rate, in-
creasing the quality of patient documentation and improved workflow patterns
[27]. This work discloses an assistive tool to help physicians to improve their
practice. The problem it addresses is predicting the survivability of colorectal
cancer patients in an individualized manner.
3.1 Requirements for the Survivability Prediction Tool
Several functionalities were delineated to achieve a solution that covers the lim-
itations mentioned in Section 2 and, at the same time, is able to help physicians
to improve their practice. These functionalities are summarized in the following
functional requirements for the prediction tool: allow the user to select the can-
cer type (either colon or rectal) for which he seeks a prediction; allow the user
to provide inputs for a set of selected features, based on which the underlying
models generate survivability predictions; allow the user to choose the value of
an input for a feature from a set of pre-determined values; provide a survivability
prediction, according to the inputs, for 1, 2, 3, 4 and 5 years after the diagnosis
and treatment; provide a likelihood value for the prediction of each year; to allow
the visualization of the predictions and likelihood values in a chart; and allow
the insertion of new patient registries into the case database, thus increasing the
number of cases for the periodic recalculation of the prediction models.
Additional requirements for the tool are that it should be made available
in the two main mobile platforms (iOS and Android) and it should be able to
recalculate the prediction models upon the addition of a significant number of
new patient registries. This confers a dynamism to the prediction models and
should ensure their evolution over time.
3.2 Colon and Rectal Cancer Survivability Prediction Models
Survivability prediction was approached as a binary classification problem. The
goal was to produce predictions for 1, 2, 3, 4 and 5 years after treatment of colon
or rectal cancer. Each classification label (there were five representing years 1,
2, 3, 4 and 5) could only have two values: survived ornot survived. As such, it
was necessary to build five survivability prediction models (one per year) for
each type of cancer. The created models were based on the SEER dataset. The
criteria for selecting patient registries was the same for both colon and rectal
cancer. Only patients with age greater than or equal to 18 years old were selected.
Patients who were alive at the end of the data collection whose survival time
had not yet reached 60 months (five years) and those who passed away of causes
other than colon or rectal cancer were sampled out. After preprocessing, 38,592
cases were isolated for colon cancer and 12,818 cases were considered for rectal
cancer. From the isolated cases for each pathology, 10% were selected for testing
sets. After filtering cases with “unknown” values, the colon cancer testing set
had 2,221 cases and the training set had 20,061 cases. The testing set for rectal
cancer had 551 cases and the training set had 4,962 cases. In total, the training
set had 61 attributes representing possible classification features.
All the phases, from preprocessing to evaluation, were executed using Rapid-
Miner4, an open source data mining software chosen for its workflow-based in-
terface and an intuitive application programming interface (API).
Using the Optimize Selection [22] operator for feature selection with the
classification labels as target, a total of 6 features were obtained from a feature
selection phase for each cancer type. Their name and description are shown in
Tables 2 and 3. The training sets for colon and rectal cancer with their respective
selected features were used in the learning of multiple prediction models using
different ML ensemble methods such as bagging, adaboost, bayesian boosting,
stacking, and voting. The accuracy, the AUC and the F-measure were used
as performance measures in order to evaluate the models developed for colon
and rectal cancer. The accuracy is the percentage of correct responses among
the examined cases [9]. The F-measure is a combination of precision (a form
of accuracy, also known as positive predictive value) and recall (also known as
sensitivity) [21]. The AUC can be interpreted as the percentage of randomly
drawn data pairs of individuals that have been accurately classified in the two
populations [16]. These measures were calculated using the training data set and
10-fold cross validation. By applying the testing sets to the models, we calculated
the percentage of incorrectly classified cases. The stacking5 [14], using k-NN,
decision tree, and random forest classifiers as base learners and a naive bayes
classifier as a stacking model learner, was the best performing model for both
colon and rectal cancer. Upon prediction, the model is capable of providing a
confidence value that represents the likelihood of the prediction. Table 4 shows
the performance values of the best model developed, for both cancer types.
4Software available at https://rapidminer.com.
5Stacking combines base classifiers of different types. Each base classifier generates
a model using the training set, then a meta-learner integrates the independently learned
base classifier models into a high level classifier by re-learning a meta-level training set.
As the intent with this paper is to present the features of the developed tool
and describe its inner workings, it was considered that an exhaustive description
of the ML process was out of scope.
Table 2: Features obtained by feature selection and used for colon cancer models.
Attribute Description
Age at diagnosis The age (in years) of the patient at time of diagnosis
Carcinoembryonic Antigen
The interpretation of the highest Carcinoembryonic
Antigen test results
Clinical Assessment of
Regional Lymph Nodes
The clinically evident regional lymph nodes
AJCC Stage The grouping of the TNM information combined
Primary Site
Identification of the site in which the primary
tumor originated
Regional Nodes Examined
The total number of regional lymph nodes that were
removed and examined by the pathologist
Table 3: Features obtained by feature selection and used for rectal cancer models.
Attribute Description
Age at diagnosis *
Extension of the Tumor Information on extension of the tumor
Tumor Size Information on tumor size (in mm)
AJCC Stage *
Surgery of Primary Site
Describes a surgical procedure that removes and/or
destroys tissue of the primary site performed as part of
the initial work-up or first course of therapy.
Gender The sex/gender of the patient at diagnosis
* Described in Table 2.
Table 4: Performance measures for 10-fold cross validation and the incorrectly
classified cases from the test data set of the stacking model.
Cancer
Type
Measure 1 Year 2 Year 3 Year 4 Year 5 Year Average
Colon
AUC 0.982 0.985 0.987 0.989 0.987 0.986
Accuracy 95.84% 96.62% 96.79% 97.09% 97.03% 96.67%
F-Measure 90.41% 94.43% 95.55% 97.61% 97.51% 95.10%
Incorrectly Classified (%) 3.24% 3.02% 2.97% 2.84% 3.11% 3.03%
Rectal
AUC 0.961 0.973 0.973 0.975 0.969 0.970
Accuracy 95.61% 95.81% 93.81% 94.82% 94.32% 94,87%
F-Measure 80.56% 87.32% 85.85% 96.63% 96.20% 89.31%
Incorrectly Classified (%) 3.81% 3.99% 6.17% 4.36% 4.36% 4.54%
3.3 Architecture
The CRCPredictor is a hybrid mobile application targeting smartphones and
tablets. The back-end of this tool includes two web services: one to give the sur-
vivability prediction responses for colon or rectal cancer to the user and another
to recalculate the survivability prediction models. Figure 1 shows the architec-
ture of the CRCPredictor system.
The Survival Prediction App was developed using a hybrid approach, between
a web and a native methodology. This allows an abstraction from the native
Fig. 1: Architecture of the CRCPredictor system.
language of the target operating system while retaining the core features of
a native app. A hybrid application is developed by applying web technologies
(mainly, HTML5, CSS and JavaScript) and is executed inside a native container
on the mobile device. It is suitable for multiple platforms and is distributable
through an application store, just like native applications. This type of approach
can have an inferior performance compared with native applications. However,
nowadays mobile devices have powerful capabilities and the performance gap is
hardly noted. The application was developed using AngularJS, Ionic Framework,
and Cordova. Cordova wraps the HTML/JavaScript app into a native container
which can access the device functions of several platforms [1]. These functions
are exposed via a unified JavaScript API, for an easy access to the full native
functionalities.
The Survival Prediction Model Server Application was developed to cover the
need of an individualized system, able to respond according to a particular set
of patient characteristics. It exposes a set of RESTful web services. This service
architecture was chosen for being light-weight, easy to access and scalable [31].
The web services were developed in Java with the Java API for RESTful Web
Services (JAX-RS) [2]. The data is sent over the HTML POST method when
the health care professional submits the values for the prediction features on
the Survival Prediction App. The RESTful web service, using the RapidMiner
API, receives the values and feeds them to the corresponding models, encoded
in XML files. The response with the survivability predictions for the five years
is returned in a JSON format.
The Online Learning Server Application also follows a REST architecture.
It handles newly submitted patient data. The outcomes are added to a database
for a posterior recalculation of all the models, which keeps them up-to-date.
The data is inserted into a NoSQL database and, for each 1000 new registries,
the models for the five years are recalculated, generating five new XML files for
the type of cancer that just got the thousandth new case. The 1000 mark was
arbitrarily defined and can be subject to adjustment.
3.4 Use Case
Figure 2a shows the first screen that appears when the Survival Prediction App
of the CRCPredictor is initiated. By clicking on the menu (Figure 2b), all options
available in this application become visible.
(a) Home screen. (b) Menu.
Fig. 2: Home screen and menu of the Survival Prediction App of the CRCPre-
dictor.
A typical use case is getting a prediction for colon cancer survivability. Sup-
posing a physician is treating a patient diagnosed with colon cancer, once the
type of cancer in the home screen is set (as shown in Figure 2b), the health care
professional inserts the values for the selected features (Figure 3a). All features,
except for the age of the patient, are filled in by choosing the value from a list of
available options. By submitting a case of a patient with 55 years old, having a
positive/elevated carcinoembryonic antigen value, with clinical assessment of re-
gional lymph nodes of not clinically evident, with the primary site of the cancer
being in the sigmoid colon, with stage 0 and with 5 as the number of regional
nodes examined, the values are sent to the Survival Prediction Model Server
Application and the outcome is calculated. The prediction is always provided in
the form of confidence values for a positive prediction, i.e., the confidence that
the patient will survive. This is displayed in a new screen in the form of a bar
chart (Figure 3b). For the stage of the patient, the physician can choose between
the TNM system or the grouped stage, known as American Joint Committee on
Cancer (AJCC) stage. The results show that, while the model was able to pre-
dict with 100% confidence that the patient will survive the first three years,
the confidence of his surviving the fourth and fifth years is 0%. To predict the
survivability of a patient diagnosed with rectal cancer, the procedure is similar
to the one used for colon cancer.
(a) Survivability Features of
Colon Cancer.
(b) Results for Colon Cancer.
Fig. 3: Colon Cancer Survivability Calculator.
4 Analysis and Discussion
In terms of inputs the constructed prediction models, for both colon and rectal
cancer, require only the input of six selected features. Comparing with the related
tools in section 2, this number is inferior to the number of features used in the
underlying models of the tools described in [10], [23], [26], and [7], and is closer
to the number of inputs of the remaining prediction tools. The number of input
features may be crucial to the adoption or the rejection of a tool, as it may
become difficult to use it on-the-fly if too much information is needed. Another
aspect to note is that, apart from the age at diagnosis and the AJCC Stage,
the feature selection produced two very different sets for colon and for rectal
cancer, which is in line with the notion that the two, although having aspects in
common, are different pathologies. Regarding the colon cancer features, the age
at diagnosis and the AJCC stage are present in most colon cancer prediction
tools [11,29,23]. The other selected features are not usually present, but they
are closely related to the ones that are. For instance, the clinical assessment of
regional lymph nodes is a product of a medical evaluation of a feature widely
used in the existing tools [29,23] that is the number of lymph nodes found to
have cancer out of the lymph nodes isolated during surgery. The same can be
said about the selected features for rectal cancer, i.e., they are, at the very least,
closely related to the ones used in other prediction tools.
In [3], the use of ML ensemble models to develop survival prediction models
for colon cancer is described. The modelling component of our work is similar
to that approach; therefore, it is possible to compare the performance of our
selected model with theirs. The classification accuracies reported in [3] for years
1, 2, and 5 were 90.38%, 88.01%, and 85.13%. The reported AUCs were 0.96,
0.95, and 0.92, respectively. As shown in Table 4, we were able to improve the
classification results with our models. This direct comparison is not possible for
the rectal cancer model as it was not possible to find such a closely related work
in the literature. However, it is possible to verify that the rectal cancer model
performs worse than the colon model in every metric, possibly due to the smaller
size of the training set used in the learning process. At the same time, both the
colon and rectal cancer models showed low classification errors on the randomly
selected test data sets. Additionally, when comparing the AUCs of the generated
models in Table 4 with the C-indexes in Table 1, it is possible to conclude that
the generated models show a better discriminative power than the currently
available models.
Regarding the CRCPredictor system, it fulfils the requirements defined at the
beginning of the work. The distinguishing features of the system’s architecture
are its flexibility and scalability, which make the addition of new features (ser-
vices) simple and easy. The Survival Prediction App was developed as a mobile-
friendly application, enabling the easy access of health care professionals to its
functionalities on their mobile devices. Another component that distinguishes
this system from established tools is the Online Learning Server Application
which ensures the continuous evolution of the prediction models. However, the
system does not provide conditional survivability predictions, which makes it
less appealing when compared with the works in [11], [26], and [7], as this is a
type of information that health care professionals generally like to know.
5 Conclusions and Future Work
The main contribution of this work is a survivability prediction tool for colon
and rectal cancer. Its distinguishing features are a balance between the num-
ber of necessary inputs and prediction performance, being mobile-friendly, and
featuring an online learning component that enables the automatic recalcula-
tion and evolution of the prediction models upon the addition of new cases.
The goal with this tool is to facilitate the access of health care professionals
to instruments capable of enriching their practice and improving their results.
Future work on the tool includes the development of conditional survivability
models that allow the user to get a prediction knowing that the patient has
already survived a number of years after diagnosis and treatment. Additionally,
we intend to conduct experiments to assess how well the tool fulfils the needs
of health care professionals and identify aspects to improve. Additionally, the
models presented herein will be considered for inclusion in a guideline-based de-
cision support system, described in [20], as a dynamic knowledge complement to
the static recommendations of clinical practice guidelines. Since colon and rectal
cancer affect mostly the elderly, this survivbility prediction apllication can be
used within a technological environment, such as the one disclosed in [13], to
provide better support to this population group.
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